Unified Data for Actionable Biomarkers
What Is BiomarkerBase?
• A manually curated database
that aggregates information
from publicly available sources
that describe the clinical use of
biomarkers.
• Provides access to biomarkers that
can’t be found through searches in
public sources.
• Links biomarker information
together by target, disease, drug,
therapeutic area, and company.
2
http://www.biomarkerbase.com
- IVD Tests cleared or approved by FDA since the end of 2002 that
utilize one or more biomarkers.
- Drugs, all FDA-approved, that include a biomarker in the label.
- Clinical Trials, phase 3 and 4, initiated since the end of 2011, which
include “marker” in the record. Phase 2 trials by Nov ‘13.
- Publications describing clinical studies that include biomarkers
from the sources above.
Current Datasets
Biomarker Definition: A nucleic acid, peptide or hormone that is potentially useful
for diagnosis, prognosis, or companion diagnosis.
3
Public sources of
biomarker information lack
connectivity and have
severe querying
limitations.
4
Query limitation #1:
Some of the most
critical information
can’t even be searched.
X
5
Query limitation #1:
Some of the most
critical information
can’t even be searched.
6
X
Query limitation #2:
Nomenclature isn’t standardized.
Search
Term
Studies
Returned
ca 125 153
ca-125 140
mucin-16 138
mucin 16 138
MUC16 0
7
8
BiomarkerBase Difference
Manually Curated
ComprehensiveClinically Focused
9
Who Uses BiomarkerBase?
Diagnostic Companies
Product development; business development; marketing
Drug Companies
Clinical trial planning; partnering; test selection
Life Science Companies
Product development; business development; marketing
Research Institutions
Licensing
10
Subscription Pricing
Single User
• $1,000 / year
• Access for one individual
Multi User
• $2,500 / year
• Unlimited users at a single
site within one company or
institution
• Multi-site licenses are also
available at discounted
pricing.
11
Amplion Research Inc.
1011 SW Emkay Drive,
Suite 200
Bend, Oregon 97702
USA
support@amplion.com
+1.503.389.1157
Contact Information
12

More Related Content

PDF
Precision Medicine: Research Presentation
PPT
Personalized Medicine: Current and Future Perspectives Personalized Medicin...
PPTX
The story of personalized medicine
PDF
FDA Regulation of Medical Devices
PDF
Clinical study approval process in the Russian Federation
PDF
Biomarker Diagnosis for Alzheimer's Disease
PPTX
Dmf ppt by jahnavi bandi
PPTX
Personalized Medicine
Precision Medicine: Research Presentation
Personalized Medicine: Current and Future Perspectives Personalized Medicin...
The story of personalized medicine
FDA Regulation of Medical Devices
Clinical study approval process in the Russian Federation
Biomarker Diagnosis for Alzheimer's Disease
Dmf ppt by jahnavi bandi
Personalized Medicine

What's hot (20)

PDF
PDF
The European Medical Device Regulations - analysis of the final text
 
PPT
Personalized medicine
PPTX
ECTD BY NITESH
PPTX
Regulatory requirement for approval of Biologics
PPTX
Clinical trial regulation in eu
PPTX
Navigating the US FDA for Combination Products
PPTX
Precision Medicine: Opportunities and Challenges for Clinical Trials
PPTX
Precision Medicine: Four Trends Make It Possible
PDF
BIOSIMILARS - Regulation and Market Trends
PDF
COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN CLINICAL RESEARCH INTERV...
PPTX
Fundamentals of Health Economics and Outcomes Research (HEOR)
PPTX
Basic terminologies in Clinical trials.pptx
PDF
Clinical trial regulation 536 2014
PPTX
Machine-learning scoring functions for molecular docking
PPTX
Clinical validation and regulation for AI medical devices
PDF
FDA Regulation of Drug and Device Advertising and Promotion -- The Basics
PPT
Medical Writing 101 (PWAC)
PPTX
Regulation of biosimilar in India
PDF
eCTD Submission process diagramm
The European Medical Device Regulations - analysis of the final text
 
Personalized medicine
ECTD BY NITESH
Regulatory requirement for approval of Biologics
Clinical trial regulation in eu
Navigating the US FDA for Combination Products
Precision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Four Trends Make It Possible
BIOSIMILARS - Regulation and Market Trends
COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN CLINICAL RESEARCH INTERV...
Fundamentals of Health Economics and Outcomes Research (HEOR)
Basic terminologies in Clinical trials.pptx
Clinical trial regulation 536 2014
Machine-learning scoring functions for molecular docking
Clinical validation and regulation for AI medical devices
FDA Regulation of Drug and Device Advertising and Promotion -- The Basics
Medical Writing 101 (PWAC)
Regulation of biosimilar in India
eCTD Submission process diagramm
Ad

Similar to Biomarker base™ Introduction (20)

PPTX
regulatory sk.pptx
PDF
Linked-spls-initial-hcls-presentation-06082012
PPTX
Regulatory Requirements for API, Biologics and Novel therapies
PDF
Biosimilars Webinar June 29, 2016 Slides
PPTX
Center for Biologics Evaluation and Research (CBER) PPT
PPTX
regulatory requirements of biologicals.pptx
PPTX
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
PPTX
Center for Biologics Evaluation and Research
PDF
Non clinical drug development. ppt
PPTX
Regulatory guidance and guidelines for filing and approval for biologics
PDF
Clinical Trials & Drug Approval Process
PPTX
Drug regulation
PDF
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Inc...
PPTX
PRODUCT AWARENESS LS.pptx
PDF
Boyce cshals-2012-linked-sp ls-final
PPTX
Role of bioinformatics in drug designing
DOCX
Ind by pankaj
PPTX
Drug Discovery Method (Bioinformatics)
PDF
Orphan Drug Designation
DOCX
NDA_ANDA_IND.docx
regulatory sk.pptx
Linked-spls-initial-hcls-presentation-06082012
Regulatory Requirements for API, Biologics and Novel therapies
Biosimilars Webinar June 29, 2016 Slides
Center for Biologics Evaluation and Research (CBER) PPT
regulatory requirements of biologicals.pptx
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
Center for Biologics Evaluation and Research
Non clinical drug development. ppt
Regulatory guidance and guidelines for filing and approval for biologics
Clinical Trials & Drug Approval Process
Drug regulation
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Inc...
PRODUCT AWARENESS LS.pptx
Boyce cshals-2012-linked-sp ls-final
Role of bioinformatics in drug designing
Ind by pankaj
Drug Discovery Method (Bioinformatics)
Orphan Drug Designation
NDA_ANDA_IND.docx
Ad

Recently uploaded (20)

PDF
1911 Gold Corporate Presentation Aug 2025.pdf
PDF
533158074-Saudi-Arabia-Companies-List-Contact.pdf
PPTX
Transportation in Logistics management.pptx
PDF
HQ #118 / 'Building Resilience While Climbing the Event Mountain
PDF
Cross-Cultural Leadership Practices in Education (www.kiu.ac.ug)
PPTX
Understanding Procurement Strategies.pptx Your score increases as you pick a ...
DOCX
Center Enamel Powering Innovation and Resilience in the Italian Chemical Indu...
PDF
Kishore Vora - Best CFO in India to watch in 2025.pdf
DOCX
Handbook of Entrepreneurship- Chapter 5: Identifying business opportunity.docx
PPTX
chapter 2 entrepreneurship full lecture ppt
PPTX
IITM - FINAL Option - 01 - 12.08.25.pptx
PDF
Susan Semmelmann: Enriching the Lives of others through her Talents and Bless...
PPTX
IMM.pptx marketing communication givguhfh thfyu
PPTX
TRAINNING, DEVELOPMENT AND APPRAISAL.pptx
PPTX
CTG - Business Update 2Q2025 & 6M2025.pptx
DOCX
80 DE ÔN VÀO 10 NĂM 2023vhkkkjjhhhhjjjj
PDF
Second Hand Fashion Call to Action March 2025
PDF
MBA2024 CGE 1.pdf file presentation 2025
PDF
Immigration Law and Communication: Challenges and Solutions {www.kiu.ac.ug)
PDF
#1 Safe and Secure Verified Cash App Accounts for Purchase.pdf
1911 Gold Corporate Presentation Aug 2025.pdf
533158074-Saudi-Arabia-Companies-List-Contact.pdf
Transportation in Logistics management.pptx
HQ #118 / 'Building Resilience While Climbing the Event Mountain
Cross-Cultural Leadership Practices in Education (www.kiu.ac.ug)
Understanding Procurement Strategies.pptx Your score increases as you pick a ...
Center Enamel Powering Innovation and Resilience in the Italian Chemical Indu...
Kishore Vora - Best CFO in India to watch in 2025.pdf
Handbook of Entrepreneurship- Chapter 5: Identifying business opportunity.docx
chapter 2 entrepreneurship full lecture ppt
IITM - FINAL Option - 01 - 12.08.25.pptx
Susan Semmelmann: Enriching the Lives of others through her Talents and Bless...
IMM.pptx marketing communication givguhfh thfyu
TRAINNING, DEVELOPMENT AND APPRAISAL.pptx
CTG - Business Update 2Q2025 & 6M2025.pptx
80 DE ÔN VÀO 10 NĂM 2023vhkkkjjhhhhjjjj
Second Hand Fashion Call to Action March 2025
MBA2024 CGE 1.pdf file presentation 2025
Immigration Law and Communication: Challenges and Solutions {www.kiu.ac.ug)
#1 Safe and Secure Verified Cash App Accounts for Purchase.pdf

Biomarker base™ Introduction

  • 1. Unified Data for Actionable Biomarkers
  • 2. What Is BiomarkerBase? • A manually curated database that aggregates information from publicly available sources that describe the clinical use of biomarkers. • Provides access to biomarkers that can’t be found through searches in public sources. • Links biomarker information together by target, disease, drug, therapeutic area, and company. 2 http://www.biomarkerbase.com
  • 3. - IVD Tests cleared or approved by FDA since the end of 2002 that utilize one or more biomarkers. - Drugs, all FDA-approved, that include a biomarker in the label. - Clinical Trials, phase 3 and 4, initiated since the end of 2011, which include “marker” in the record. Phase 2 trials by Nov ‘13. - Publications describing clinical studies that include biomarkers from the sources above. Current Datasets Biomarker Definition: A nucleic acid, peptide or hormone that is potentially useful for diagnosis, prognosis, or companion diagnosis. 3
  • 4. Public sources of biomarker information lack connectivity and have severe querying limitations. 4
  • 5. Query limitation #1: Some of the most critical information can’t even be searched. X 5
  • 6. Query limitation #1: Some of the most critical information can’t even be searched. 6 X
  • 7. Query limitation #2: Nomenclature isn’t standardized. Search Term Studies Returned ca 125 153 ca-125 140 mucin-16 138 mucin 16 138 MUC16 0 7
  • 8. 8
  • 10. Who Uses BiomarkerBase? Diagnostic Companies Product development; business development; marketing Drug Companies Clinical trial planning; partnering; test selection Life Science Companies Product development; business development; marketing Research Institutions Licensing 10
  • 11. Subscription Pricing Single User • $1,000 / year • Access for one individual Multi User • $2,500 / year • Unlimited users at a single site within one company or institution • Multi-site licenses are also available at discounted pricing. 11
  • 12. Amplion Research Inc. 1011 SW Emkay Drive, Suite 200 Bend, Oregon 97702 USA support@amplion.com +1.503.389.1157 Contact Information 12